- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
SORL1 antibody detects Sortilin-related receptor, encoded by the SORL1 gene on chromosome 11q23.3. SORL1 antibody is widely used in research on protein trafficking, Alzheimer's disease, and neurodegeneration. Also known as SORLA, SORL1 belongs to the VPS10 domain receptor family, which regulates intracellular sorting of cargo proteins. SORL1 is highly expressed in neurons, adipose tissue, and liver, where it directs trafficking of lipoproteins, growth factors, and amyloid precursor protein (APP). Its ability to regulate APP processing makes it central to Alzheimer's disease biology.
Structurally, SORL1 is a large type I transmembrane receptor with an extracellular VPS10 domain, LDL receptor repeats, EGF repeats, and fibronectin-type domains. These motifs mediate binding to diverse ligands, including APP, ApoE, and neurotrophic factors. The cytoplasmic tail contains sorting signals that interact with adaptor proteins, ensuring proper endocytic recycling and lysosomal targeting. This modular design allows SORL1 to function as a key regulator of protein trafficking in neurons and other cells.
Functionally, SORL1 reduces amyloidogenic processing of APP by directing it toward recycling pathways rather than amyloidogenic cleavage in endosomes. This protective role against amyloid beta accumulation makes SORL1 central in Alzheimer's disease research. SORL1 also regulates lipoprotein metabolism, endocytosis of growth factors, and intracellular signaling pathways. Knockdown or mutation of SORL1 leads to increased amyloidogenic APP processing, impaired synaptic function, and altered lipid homeostasis. Researchers use SORL1 antibody to study these trafficking and signaling mechanisms.
Clinically, SORL1 mutations and polymorphisms are strongly associated with Alzheimer's disease risk. Reduced expression of SORL1 correlates with increased amyloid plaque burden in patient brains. Beyond Alzheimer's, SORL1 variants are linked to obesity, cardiovascular disease, and psychiatric disorders. SORL1 also has implications in cancer biology, where altered trafficking influences signaling pathways. NSJ Bioreagents provides SORL1 antibody to support research in neurodegeneration, metabolism, and receptor trafficking.
Experimentally, SORL1 antibody is used in western blotting to detect the ~250 kDa protein, in immunofluorescence microscopy to analyze intracellular trafficking, and in immunohistochemistry to study brain tissue expression. Immunoprecipitation with SORL1 antibody reveals APP-SORL1 complexes and trafficking networks.
Optimal dilution of the SORL1 antibody should be determined by the researcher.
E.coli-derived human SORLA/SORL1 recombinant protein (Position: D282-K708) was used as the immunogen for the SORL1 antibody.
After reconstitution, the SORL1 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.